Kim S. Fennebresque
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Wells Fargo Downgrades Ally Financial to Equal-Weight. Wells Fargo downgraded Ally Financial to Equal-Weight and lowered its price target to $42. This action stands out against a broader analyst consensus that currently averages a $51.95 target. The stock is trading near its 52-week low, reflecting recent market pressure despite a valuation that some analysts view as undervalued.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
ACI Faces Q2 Sales Pressure Amid Store Closures. Albertsons is expected to report second-quarter results below analyst consensus, with RBC noting a larger-than-expected decline in identical sales. The company continues to close stores at a recently acquired chain while facing price competition from Walmart. UBS highlights potential upside from its ACI Edge program despite near-term grocery challenges.
Transaction History
| BXC | ▼ Sell | Open Market | 34,138 | $2.9M | 8/6/2026 | View on chart |
| BXC | ▲ Buy | Option Exercise | 3,218 | — | 5/19/2026 | View on chart |
| ALLY | ▲ Buy | Grant | 3,632 | $153K | 5/15/2026 | View on chart |
| ACI | ▲ Buy | Option Exercise | 9,471 | — | 3/2/2026 | View on chart |
| ACI | ▲ Buy | Option Exercise | 5,158 | — | 3/2/2026 | View on chart |
| BXC | ▲ Buy | Option Exercise | 2,234 | — | 5/17/2025 | View on chart |
| ALLY | ▲ Buy | Grant | 4,266 | $153K | 5/15/2025 | View on chart |
| ACI | ▲ Buy | Option Exercise | 6,894 | $142K | 2/24/2025 | View on chart |
| BXC | ▲ Buy | Option Exercise | 2,601 | — | 5/18/2024 | View on chart |
| ALLY | ▲ Buy | Grant | 3,528 | $145K | 5/15/2024 | View on chart |
| ACI | ▲ Buy | Option Exercise | 7,724 | — | 2/26/2024 | View on chart |
| BXC | ▲ Buy | Option Exercise | 1,926 | — | 5/19/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 5,673 | $145K | 5/15/2023 | View on chart |
| ACI | ▲ Buy | Option Exercise | 6,717 | — | 2/27/2023 | View on chart |
| BXC | ▲ Buy | Option Exercise | 3,003 | — | 5/20/2022 | View on chart |
| ALLY | ▲ Buy | Grant | 3,664 | $145K | 5/13/2022 | View on chart |
| ACI | ▲ Buy | Option Exercise | 7,870 | — | 2/28/2022 | View on chart |
| BXC | ▼ Sell | Open Market | 4,264 | $215K | 9/15/2021 | View on chart |
| BXC | ▼ Sell | Open Market | 3,055 | $162K | 9/14/2021 | View on chart |
| BXC | ▼ Sell | Open Market | 3,500 | $188K | 9/13/2021 | View on chart |
| BXC | ▼ Sell | Open Market | 9,693 | $542K | 9/10/2021 | View on chart |
| BXC | ▼ Sell | Other | 3,360 | $186K | 9/9/2021 | View on chart |
| BXC | ▼ Sell | Other | 5,977 | $342K | 9/7/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
BXC: BlueLinx Expands Deal with Westlake Royal Products
BlueLinx announced an expanded partnership with Westlake Royal Building Products, adding exclusive distribution of Kleer® PVC trim and extending market reach for TruExterior® siding and trim. The agreement broadens BlueLinx’s product offerings and could enhance its presence in the building materials market. In a separate note, Citizens Research initiated coverage of BlueLinx with a Market Perform rating.
BXC: BlueLinx Expands Deal with Westlake Royal Products. BlueLinx announced an expanded partnership with Westlake Royal Building Products, adding exclusive distribution of Kleer® PVC trim and extending market reach for TruExterior® siding and trim. The agreement broadens BlueLinx’s product offerings and could enhance its presence in the building materials market. In a separate note, Citizens Research initiated coverage of BlueLinx with a Market Perform rating.